Regal Investment Advisors LLC Tandem Diabetes Care Inc Transaction History

Regal Investment Advisors LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 26, 2019	SELL	$54.41 - $71.7 $206,758 - $272,460	-3,800 Closed	0 $0
Q1 2019 May 09, 2019	SELL	$32.25 - $73.56 $203,175 - $463,428	-6,300 Reduced 62.38%	3,800 $241,000
Q4 2018 Feb 04, 2019	BUY	$28.45 - $40.65 $287,345 - $410,565	10,100 New	10,100 $383,000

359

72.5M

3.36M

229K

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $1.85B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

Get notified when there are updates to the investment portfolio of Regal Investment Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Regal Investment Advisors LLC with notifications on news.